FDA approves biosimilar to J&J?s Remicade for multiple diseases

[ahlam1399]

FDA approves biosimilar to J&J?s Remicade for multiple diseases
(Reuters) - The U.S. Food and Drug Administration on Tuesday approved Inflectra, a cheaper version of Johnson & Johnson's drug Remicade, to treat Crohn's disease, ulcerative colitis, rheumatoid arthritis, psoriasis and arthritis of the spine.


http://rc.feedsportal.com/r/247396958175/u/49/f/654207/c/35217/s/4ebe7092/sc/19/rc/1/rc.img (http://rc.feedsportal.com/r/247396958175/u/49/f/654207/c/35217/s/4ebe7092/sc/19/rc/1/rc.htm)

http://rc.feedsportal.com/r/247396958175/u/49/f/654207/c/35217/s/4ebe7092/sc/19/rc/2/rc.img (http://rc.feedsportal.com/r/247396958175/u/49/f/654207/c/35217/s/4ebe7092/sc/19/rc/2/rc.htm)

http://rc.feedsportal.com/r/247396958175/u/49/f/654207/c/35217/s/4ebe7092/sc/19/rc/3/rc.img (http://rc.feedsportal.com/r/247396958175/u/49/f/654207/c/35217/s/4ebe7092/sc/19/rc/3/rc.htm)

http://da.feedsportal.com/r/247396958175/u/49/f/654207/c/35217/s/4ebe7092/sc/19/a2.img (http://da.feedsportal.com/r/247396958175/u/49/f/654207/c/35217/s/4ebe7092/sc/19/a2.htm)
http://adchoice.feedsportal.com/r/247396958175/u/49/f/654207/c/35217/s/4ebe7092/sc/19/ach.img (http://adchoice.feedsportal.com/r/247396958175/u/49/f/654207/c/35217/s/4ebe7092/sc/19/ach.htm)http://pi.feedsportal.com/r/247396958175/u/49/f/654207/c/35217/s/4ebe7092/sc/19/a2t.imghttp://pi2.feedsportal.com/r/247396958175/u/49/f/654207/c/35217/s/4ebe7092/sc/19/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4ebe7092/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=lYxWja1js04:nuvbqE9zS18:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=lYxWja1js04:nuvbqE9zS18:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=lYxWja1js04:nuvbqE9zS18:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=lYxWja1js04:nuvbqE9zS18:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=lYxWja1js04:nuvbqE9zS18:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/lYxWja1js04